Family Medicine · Los Angeles, CA
NPI
1942352315
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1115 S Robertson Blvd
Los Angeles, CA, 90035
Phone (310) 659-9999
Groups this clinician bills Medicare through
Medicare paid, 2024
$941K
16,586 services
Medicare patients, 2024
688
Average age 77
Drug cost, 2024
$3.9M
22,635 prescriptions
Company payments, 2025
$2,364
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mehrdad Pakdaman was code 99213 (office e&m - established), 10,671 times for 673 patients. In total Mehrdad Pakdaman billed 16,586 services in 38 codes, and Medicare paid $941K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 10,671 | 673 | $69.48 | $741K |
| 36415 Venipuncture Blood Collection | Office | 1,387 | 534 | $8.65 | $12K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 1,120 | 354 | $0.96 | $1,079 |
| 96377 Injections and Infusions (nononcologic) | Office | 397 | 49 | $14.55 | $5,777 |
| 93000 Electrocardiogram | Office | 336 | 263 | $10.85 | $3,644 |
| 96372 Injection Administration | Office | 286 | 156 | $11.23 | $3,212 |
| J3121 Injection, testosterone enanthate, 1 mg | Office | 257 | 30 | $0.04 | $10 |
| G0008 Administration of influenza virus vaccine | Office | 189 | 189 | $35.02 | $6,619 |
| 90653 Vaccine Product | Office | 186 | 186 | $73.70 | $14K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 177 | 84 | $0.35 | $61.66 |
| 93978 Duplex Scan - Extremity Arteries | Office | 158 | 158 | $119.60 | $19K |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 157 | 157 | $93.74 | $15K |
| 93306 Echocardiography (TTE/TEE) | Office | 142 | 142 | $133.25 | $19K |
| 93970 Duplex Scan - Extremity Veins | Office | 139 | 139 | $120.97 | $17K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 134 | 134 | $153.16 | $21K |
By year: 2022 $1.1M for 13,776 services; 2023 $1.3M for 18,006 services; 2024 $941K for 16,586 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,387 | 534 | $8.65 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Mehrdad Pakdaman prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,574 prescriptions and refills. In total Mehrdad Pakdaman wrote 22,635 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,574 | 2,782 | 311 | $6,080 |
| Metoprolol Succinate Generic | 908 | 1,498 | 152 | $7,831 |
| Rosuvastatin Calcium Generic | 873 | 1,384 | 147 | $5,952 |
| Vascepa Icosapent Ethyl | 829 | 995 | 128 | $313K |
| Amlodipine Besylate Generic | 757 | 1,322 | 148 | $2,067 |
| Losartan Potassium Generic | 719 | 1,275 | 150 | $2,817 |
| Olmesartan Medoxomil Generic | 569 | 894 | 92 | $4,965 |
| Gabapentin Generic | 541 | 639 | 79 | $2,104 |
| Levothyroxine Sodium Generic | 458 | 725 | 75 | $2,463 |
| Linzess Linaclotide | 452 | 521 | 74 | $269K |
| Dexlansoprazole Dr Dexlansoprazole | 415 | 435 | 54 | $72K |
| Clonazepam Generic | 413 | 416 | 99 | $646 |
| Metformin Hcl Er Metformin Hcl | 395 | 612 | 72 | $1,165 |
| Tamsulosin Hcl Generic | 372 | 598 | 70 | $2,642 |
| Metformin Hcl Generic | 367 | 640 | 72 | $1,568 |
Brand drugs: 4,637 claims; generic drugs: 17,868 claims; opioid claims: 143.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mehrdad Pakdaman $2,364 ($2,364 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $577.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 15 | $577 |
| Amgen Inc. AMGN | 14 | $319 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $296 |
| Genzyme Corporation SNY | 6 | $212 |
| Shield Therapeutics Inc STX.L | 16 | $186 |
| Abbvie Inc. ABBV | 6 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $103 |
| Ardelyx, Inc. ARDX | 2 | $64.16 |
| Axsome Therapeutics, Inc. AXSM | 2 | $58.84 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $57.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.